Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Nov 2016 for Fate Therapeutics INC, €94k.
Filing timeline
BuySaleChris Storgard
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +41.1%Entry US$3.09 · Close at T+365 US$4.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chris Storgard: trading record in brief
All filings by Chris Storgard on record concern Fate Therapeutics Inc. Between 16 May 2016 and 23 November 2016, the trades on record add up to 2 filings.
Every open-market trade on record is a purchase: 1 purchase worth €94k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant.
On 28 November 2016 came the latest disclosure, an open-market purchase for €94k in Fate Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Chris Storgard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
37,593 shares@ US$2.66100.0% of flowCommon StockSEC:0001209191-16-152160:0
Canonical exit: 21 Feb 2017 (T+90)
9,090 shares0Common StockSEC:0001209191-16-121180:0
2 of 2 declarations
